Fig. 3From: Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot programChange in attack duration plotted by patient. While 102 patients had a reduction, 75 had no change and eight had an increase. Five patients did not report the dataBack to article page